Barriers and Solutions for Prescribing Obesity Pharmacotherapy

• Autores: Ken Fujioka, Samantha R. Harris
• Localización: Endocrinology and metabolism clinics of North America, ISSN 0889-8529, Vol. 49, Nº. 2, 2020 (Ejemplar dedicado a: Obesity), págs. 303-314
• Idioma: inglés
• Texto completo no disponible (Saber más ...)
• Resumen

  • There are many valid reasons why health care providers are reluctant to use pharmacotherapy for weight management: the negative track record of weight loss medications has led to numerous safety concerns, and there is lack of formal training in obesity medicine and a general discomfort with using these medications. New medications have improved safety profiles, and their mechanisms are based on recent discoveries of how humans regulate weight. This, combined with a change in American health coverage, has slowly increased the use weight loss medication. This article examines the barriers and changes that are increasing the use of anti-obesity medications.